The gain-of-function mutation Q41L of GRK5 is of particular interest, not only because this mutation has a protective effect against heart failure, which may have a further therapeutic implication10, but also because this mutation is crucial for understanding the mechanism by which GRKs recognize and interact with GPCRs. This evidence concerns the gene GRK5 and heart failure.